76 related articles for article (PubMed ID: 31746108)
1. Four transcription profile-based models identify novel prognostic signatures in oesophageal cancer.
Liu T; Fang P; Han C; Ma Z; Xu W; Xia W; Hu J; Xu Y; Xu L; Yin R; Wang S; Zhang Q
J Cell Mol Med; 2020 Jan; 24(1):711-721. PubMed ID: 31746108
[TBL] [Abstract][Full Text] [Related]
2. Construction of an immune-related prognostic model and potential drugs screening for esophageal cancer based on bioinformatics analyses and network pharmacology.
Qi P; Qi B; Gu C; Huo S; Dang X; Liu Y; Zhao B
Immun Inflamm Dis; 2024 May; 12(5):e1266. PubMed ID: 38804848
[TBL] [Abstract][Full Text] [Related]
3. A pathway-based computational framework for identification of a new modal of multi-omics biomarkers and its application in esophageal cancer.
Zhou Q; Ye W; Yu X; Bao YJ
Comput Methods Programs Biomed; 2024 Apr; 247():108077. PubMed ID: 38382307
[TBL] [Abstract][Full Text] [Related]
4. A novel machine learning approach reveals latent vascular phenotypes predictive of renal cancer outcome.
Ing N; Huang F; Conley A; You S; Ma Z; Klimov S; Ohe C; Yuan X; Amin MB; Figlin R; Gertych A; Knudsen BS
Sci Rep; 2017 Oct; 7(1):13190. PubMed ID: 29038551
[TBL] [Abstract][Full Text] [Related]
5. Enhancing breast cancer outcomes with machine learning-driven glutamine metabolic reprogramming signature.
Li X; Li X; Yang B; Sun S; Wang S; Yu F; Wang T
Front Immunol; 2024; 15():1369289. PubMed ID: 38756785
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
Liu T; Han C; Fang P; Zhu H; Wang S; Ma Z; Zhang Q; Xia W; Wang J; Xu L; Yin R
Cell Mol Life Sci; 2021 Mar; 78(5):1983-2000. PubMed ID: 33170304
[TBL] [Abstract][Full Text] [Related]
7. LINC00673 Represses CDKN2C and Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells by EZH2-Mediated H3K27 Trimethylation.
Zhou M; Mao Y; Yu S; Li Y; Yin R; Zhang Q; Lu T; Sun R; Lin S; Qian Y; Xu Y; Fan H
Front Oncol; 2020; 10():1546. PubMed ID: 33014799
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
Zheng X; Zhang J; Fang T; Wang X; Wang S; Ma Z; Xu Y; Han C; Sun M; Xu L; Wang J; Yin R
Oncogenesis; 2020 Mar; 9(3):34. PubMed ID: 32165621
[TBL] [Abstract][Full Text] [Related]
9. A Prognostic Model for Colon Cancer Patients Based on Eight Signature Autophagy Genes.
Xu J; Dai S; Yuan Y; Xiao Q; Ding K
Front Cell Dev Biol; 2020; 8():602174. PubMed ID: 33324651
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for cancer-associated fibroblasts.
Han C; Liu T; Yin R
Biomark Res; 2020 Nov; 8(1):64. PubMed ID: 33292666
[TBL] [Abstract][Full Text] [Related]
11. Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma.
Wang S; Du M; Zhang J; Xu W; Yuan Q; Li M; Wang J; Zhu H; Wang Y; Wang C; Gong Y; Wang X; Hu Z; Christiani DC; Xu L; Shen H; Yin R
Nat Commun; 2020 Nov; 11(1):6083. PubMed ID: 33247113
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
13. A novel microRNA signature for pathological grading in lung adenocarcinoma based on TCGA and GEO data.
Yang Z; Yin H; Shi L; Qian X
Int J Mol Med; 2020 May; 45(5):1397-1408. PubMed ID: 32323746
[TBL] [Abstract][Full Text] [Related]
14. A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.
Huang R; Mao M; Lu Y; Yu Q; Liao L
Aging (Albany NY); 2020 Apr; 12(8):6966-6980. PubMed ID: 32310824
[TBL] [Abstract][Full Text] [Related]
15. Systematic construction and validation of an immune prognostic model for lung adenocarcinoma.
Luo C; Lei M; Zhang Y; Zhang Q; Li L; Lian J; Liu S; Wang L; Pi G; Zhang Y
J Cell Mol Med; 2020 Jan; 24(2):1233-1244. PubMed ID: 31779055
[TBL] [Abstract][Full Text] [Related]
16. Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR.
Zheng L; Li L; Xie J; Jin H; Zhu N
J Cancer; 2021; 12(3):899-911. PubMed ID: 33403046
[TBL] [Abstract][Full Text] [Related]
17. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L
Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI).
Ayo A; Figueras E; Schachtsiek T; Budak M; Sewald N; Laakkonen P
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32650473
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma.
Liu T; Han C; Fang P; Ma Z; Wang X; Chen H; Wang S; Meng F; Wang C; Zhang E; Dong G; Zhu H; Yin W; Wang J; Zuo X; Qiu M; Wang J; Qian X; Shen H; Xu L; Hu Z; Yin R
J Hematol Oncol; 2022 Oct; 15(1):141. PubMed ID: 36209111
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex-mediated changes in chromatin structure in lung adenocarcinoma.
Fang P; Chen H; Ma Z; Han C; Yin W; Wang S; Zhu H; Xia W; Wang J; Xu L; Liu T; Yin R
Cancer Commun (Lond); 2021 Jul; 41(7):596-614. PubMed ID: 34105888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
